Ganoderma lucidum Polysaccharides Inhibit Malignant Phenotype of Hepatocellular Carcinoma Cells by Regulating PI3K/Akt Signaling Pathway
10.13422/j.cnki.syfjx.2022002023
- VernacularTitle:灵芝多糖调控PI3K/Akt信号通路抑制肝癌细胞恶性表型
- Author:
Rui SHEN
1
;
Jing XU
1
;
Lei WANG
1
;
Biao CAI
1
;
Hang SONG
1
Author Information
1. Anhui University of Chinese Medicine, Hefei 230012, China
- Publication Type:Journal Article
- Keywords:
Ganoderma lucidum polysaccharides;
liver cancer;
cell experiment;
malignant phenotype;
phosphatidylinositol3 kinase/protein kinase B (PI3K/Akt) signaling pathway
- From:
Chinese Journal of Experimental Traditional Medical Formulae
2023;29(6):88-94
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the effect of Ganoderma lucidum polysaccharides (GLP) on the proliferation, migration, cycle, and apoptosis of hepatocellular carcinoma SKHEP1 and Huh7 cells and to explore the underlying mechanism. MethodSK-HEP-1 and Huh-7 cells were classified into the blank group and low-, medium-, and high-dose GLP groups (3.5, 7, 14 g·L-1). The proliferation of the cells was examined by cell counting kit-8 (CCK8) assay, and the migration by scratch assay. Cell cycle was measured by flow cytometry and apoptosis was detected based on Hoechst33258 staining. In addition, the expression of phosphatidylinositol 3-kinase (PI3K), protein kinase B (Akt), phosphorylated PI3K (pPI3K), and phosphorylated Akt (pAkt) in the cells was determined by Western blot. ResultCompared with the blank group, the three doses of GLP reduced the proliferation and migration of SKHEP1 and Huh7 cells (P<0.05), increased the percentage of cells in G1 phase (P<0.05), and decreased percentage of cells in S and G2 phase (P<0.05). In addition, the three doses can induce apoptosis of both SK-HEP-1 and Huh-7 cells, particularly the high dose. Moreover, the three doses of GLP lowered the levels of pPI3K and pAkt (P<0.05). ConclusionGLP significantly inhibited the malignant phenotype of SK-HEP-1 and Huh-7 cells through the PI3K/Akt signaling pathway.